Question

Describe the etiology, signs, and symptoms of malignant hyperthermia; the drugs associated with a high risk...

  1. Describe the etiology, signs, and symptoms of malignant hyperthermia; the drugs associated with a high risk for that condition; and interventions to be implemented should it develop.
  2. Identify the class of drugs used to reverse the effects of nondepolarizing neuromuscular blockers and describe the mechanism by which they cause that reversal. Also explain why pharmacologic reversal is not used when succinylcholine is the neuromuscular blocker.
  3. Describe the signs and symptoms associated with “irreversible” cholinesterase inhibitors and the general approaches used to manage poisoning caused by these substances.
  4. Describe the signs and symptoms associated with cholinesterase inhibitor overdose and the general approaches to managing it.
0 0
Add a comment Improve this question Transcribed image text
Answer #1

1.

malignant hyperthermia is a fatal condition which occurred due to hypermetabolism of skeletal muscles. It is an inherited disorder with an abnormal ryanodine receptor.

aetiology

  • certain inhalational anaesthetic agents  
  • depolarising muscle relaxants.(succinylcholine)

Abnormal ryanodine receptor interferes with the regulation of calcium in the muscle, results in massive muscle reaction

signs and symptoms

EARLY SIGNS

  • muscle rigidity
  • respiratory and metabolic acidosis
  • increased carbon dioxide concentration
  • tachycardia
  • tachypnea
  • hyperkalemia

LATER SIGNS

  • hyperthermia
  • myoglobinuria
  • multiple organ failure.

drugs associated with malignant hyperthermia

volatile anaesthetic gases: halothane, sevoflurane, desflurane, isoflurane, enflurane

depolarizing muscle relaxants: suxamethonium, decamethonium.

interventions

  • cool mist and fans or cooling blankets to lower temperature.
  • administer cooled intravenous fluids.
  • administer oxygen
  • administer antihypertensive drugs
  • administer dantrolene to reverse reaction

2.

the direct-acting skeletal muscle relaxant is the drug of classification of dantrolene, used as an antidote for malignant hyperthermia.

if any signs of developing malignant hyperthermia with triggering medicine, immediately stop the medicine. administer dantrolene (dantrium). it relaxes the muscle and ceases massive muscle metabolism.

succinylcholine is the depolarising agent which has a short term action of 5 minutes. no cholinergic agents are used currently to reverse the reaction other than time. use of cholinergic worsens the condition. the only management is the administration of artificial respiration and gives time to subside. if the effect is prolonging, intubation and use of ventilator till the effect subside.

Add a comment
Know the answer?
Add Answer to:
Describe the etiology, signs, and symptoms of malignant hyperthermia; the drugs associated with a high risk...
Your Answer:

Post as a guest

Your Name:

What's your source?

Earn Coins

Coins can be redeemed for fabulous gifts.

Not the answer you're looking for? Ask your own homework help question. Our experts will answer your question WITHIN MINUTES for Free.
Similar Homework Help Questions
  • Describe the main effects of cholinesterase inhibitors on structures controlled by the autonomic nervous system and...

    Describe the main effects of cholinesterase inhibitors on structures controlled by the autonomic nervous system and on skeletal muscle, and state the general mechanism by which these effects occur. Compare and contrast the effects of the cholinesterase inhibitors with those of bethanechol, which was described as the most representative muscarinic agonist (see Chapter 14). State the main clinical uses of cholinesterase inhibitors and precautions for and contraindications to their use. Recognize the meaning and importance of the term quaternary when...

  • 1. Describe the anatomy of the somatic nervous system, the key transmitter and receptor type involved...

    1. Describe the anatomy of the somatic nervous system, the key transmitter and receptor type involved in skeletal muscle activation, and the physiologic consequences of activating those cell receptors. 2. Compare and contrast the mechanisms of action of nondepolarizing and depolarizing neuromuscular blocking agents and state how these actions influence the use of one class rather than the other in specified clinical situations. 3. Identify three specific uses for neuromuscular blocking agents and describe the monitoring and other measures necessary...

ADVERTISEMENT
Free Homework Help App
Download From Google Play
Scan Your Homework
to Get Instant Free Answers
Need Online Homework Help?
Ask a Question
Get Answers For Free
Most questions answered within 3 hours.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT